Papers in this category present clinical research that has a clear potential to optimize patient care, with particular emphasis on high quality randomized controlled trials, novel combination treatments, therapies, novel diagnostic or prognostic insights and new insights into mechanism of action.
Saskia Santegoets, PhD
VU University Medical Center Cancer Center Amsterdam
“Myeloid derived suppressor and dendritic cell subsets are related to clinical outcome in prostate cancer patients treated with prostate GVAX and ipilimumab”
Saskia Santegoets, Anita Stam, Sinéad M. Lougheed, Helen Gall, Karin Jooss, Natalie Sacks, Kristen Hege, Israel Lowy, Rik J. Scheper, Winald R. Gerritsen, Alfons van den Eertwegh, Tanja D. de Gruijl
Journal for Immunotherapy of Cancer 2014, 2:31